Enriching lives is why we exist, it is what we aim to accomplish and it is the promise of our brand to all the lives we touch. We at Glenmark truly live this by discovering innovative molecules to address evolving needs of patients and producing effective medicines to help people lead fuller, healthier and happier lives.
Our evolution into a leading player in the drug discovery market has been fueled by our dedication to find cures for unmet medical needs. Glenmark has several first-in-class molecules, both NCE’s (New Chemical Entities) and NBE’s (New Biological Entities), in various stages of pre-clinical and clinical development. We have made a mark for ourselves in this area by out-licensing seven of our molecules to leading multinationals. Our drug discovery efforts are focused in the therapeutic segments of Inflammation, Pain and Oncology.
Our rapidly growing Formulations business services the requirements of everyone, be it the developed markets of US and Europe or the emerging ones of India, Russia and Brazil. With a commercial presence in more than 80 countries we are able to positively impact over a 100 million lives.
Each Glenmark employee across our offices in over 40 nations, 17 manufacturing facilities and 5 R&D centres is committed to ‘enriching lives to create a healthier and happier world.’